Capital Markets Day: Commercial Execution and Innovation in Obesity Care
13
Commercial execution and innovation
Obesity care
The number of physicans prescribing WegovyⓇ has already
surpassed SaxendaⓇ
Total number of prescribers has
already surpassed SaxendaⓇ
Current WegovyⓇ prescribers
Prescribers (in 000s)
12
10
8
6
4
35%
48%
Prescriber engagement
Novo NordiskⓇ
Dedicated sales force and medical liaisons
•
Sales force-250 reps
•
Call plan targeting ~35k
physicians
• Medical liaisons providing
education
Medical education
2
8%
9%
0
Rethink
ObesityⓇ
Jun
2021
Feb
2022
Nurse practitioner/Physician assistant
Primary care physician
-SaxendaⓇ
-WegovyⓇ
Endocrinologist
Other
TW: Total writers; FTW: First time writers; HCP: Health care providers
•
•
Advance understanding of
obesity as a chronic disease
Educate providers on evidence-
based clinical interventions
Communicate impact of
treatment on complications
and quality of life
CMD22
CAPITAL MARKETS DAYView entire presentation